PRESSEPORTAL Presseportal Logo
Alle Storys
Folgen
Keine Story von Girindus AG i.L. mehr verpassen.

24.08.2000 – 08:36

Girindus AG i.L.

ots Ad hoc-Service: Girindus AG

Bergisch-Gladbach (ots Ad hoc-Service) -

The sender is solely responsible for the contents of this
announcement.
. Sales and earnings according to plan 
   . Reorientation accelerated
   . High investments in R&D, technologies and personnel 
   . 6 new APIs: just the beginning
Sales and earnings of Girindus AG developed according to plan in
the first six months of FY 2000. At DEM 12.3 million, first-half
sales reached almost exactly the targeted DEM 12.4 million. Earnings
per share stood at a negative DEM 0.56 compared to a planned negative
DEM 0.51. At a negative DEM 3.8 million, the operating result was
better than the projected DEM 4.2 million. Girindus has clearly
accelerated its development into the leading one-stop-shop- supplier
of innovative therapeutic active pharmaceutical ingredients (APIs)
based on small molecules, proteins/enzymes, oligonucleotides/plasmide
DNA and carbohydrates. Six new APIs with high margins have already
been acquired. But this is just the beginning. "Our reorientation
into a highly profitable one-stop-shop-supplier of innovative
next-generation APIs will result in additional API projects with high
margins in the near future. Another 4 API inquiries are currently
being processed," said Board Chairman Fritz Link. The sales potential
per API is approx. DM 50 million if the drug obtains official
approval. Girindus will constantly have a large number of APIs in its
pipeline. Its acknowledged expertise and comprehensive know-how makes
Girindus the preferred partner of the pharmaceutical and
biopharmaceutical industry when it comes to developing API cost- and
time-effective up to the final approval stage. Girindus offers
process development, Scale-Up, regulatory support and commercial
production in cGMP compliance applying technologies of biotechnology
and chemistry.
Press contact: Haubrok AG Kaistraße 8 40221 Düsseldorf Tel.:
0211/30 126-116 Fax: 0211/30 126-198 E-Mail: ms@haubrok-ir.de
End
Internet: http://recherche.newsaktuell.de

Original-Content von: Girindus AG i.L., übermittelt durch news aktuell